Surrogate markers of insulin resistance in assessing individuals with new categories "prehypertension" and "prediabetes"

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 1, 2007, Pages 35-39

  Kanauchi, Masao ^a   Kanauchi, Kimiko ^b   Inoue, Tomoko ^b   Kimura, Kuniko ^a   Saito, Yoshihiko ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b SHARP CORPORATION   (Japan)

Author keywords

75 g oral glucose tolerance test; Insulin resistance; Metabolic syndrome; Prediabetes; Prehypertension

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GLUCOSE TOLERANCE; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; JAPANESE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PATIENT ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RISK;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; MIDDLE AGED; PREDIABETIC STATE;

EID: 33846534228     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2007.015     Document Type: Article

References (24)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC-7 Report. J Am Med Assoc 2003;289:2560-72.
3. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-7.
4. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27(Suppl 1):S5-10.
5. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study. Lancet 2001;358:1682-6.
6. Liszka H, Mainous AG III, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann Fam Med 2005;3:294-9.
7. Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR, et al. Pre-hypertension, diabetes, and cardiovascular disease risk in a population-base sample. Hypertension 2006;47:410-4.
8. Deedwania PC, Fonseca VA. Diabetes, prediabetes, and cardiovascular risk. Am J Med 2005;118:939-47.
9. Alberti KG, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005;366:1059-62.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment. Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in men. Diabetologia 1985;28:412-9.
11. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999;22:1462-70.
12. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T, et al. Use of oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295-301.
13. Mari A, Pacini G, Murphy E, Ahren B. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001;24:539-48.
14. Kanauchi M, Tsujimoto N, Hashimoto T. Validation of simple indices to assess insulin sensitivity based on the oral glucose tolerance test in the Japanese population. Diabetes Res Clin Pract 2002;55:229-35.
15. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-508.
16. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
17. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990;39:167-74.
18. Falkner B, Hulman S, Kushner H. Insulin-stimulated glucose utilization and borderline hypertension in young adult blacks. Hypertension 1993;22:18-25.
19. Piccardo MG, Turchetti G, Rosa MS, Pacini G. Elevated basal insulin secretion and normal dynamic insulin sensitivity in borderline hypertension. Nutr Metab Cardiovasc Dis 1999;9:244-9.
20. Cordero A, Laclaustra M, Leon M, Grima A, Casusnovas JA, Lueng E, et al. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. Am J Hypertens 2006;19:189-96.
21. Weyer C, Bogardus C, Pratley RE. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 1999;48:2197-203.
22. Garcia-Puig J, Ruilope LM, Luque M, Fernandez J, Ortega R, Dal-Re R, et al. Glucose metabolism in patients with essential hypertension. Am J Med 2006;119:318-26.
23. Lind L, Berne C, Lithell H. Prevalence of insulin resistance in essential hypertension. J Hypertens 1995;13:1457-62.
24. Ruderman N, Chisholm D, Pi-Sunyer X, Schneuder S. The metabolically obese, normal-weight individual revisited. Diabetes 1998;47:699-713.